Pharmaceutical services firm Hvivo, formerly Open Orphan, reported a 44pc rise in earnings in 2023 in a “record year across all financial and operational metrics.” Earnings before interest, taxes, depreciation

Introduction A biotech company developing a treatment for cancer and immune disorders planned to conduct their Phase 1b clinical trial in the United States (US). They approached Venn Life Sciences

Andrew will be discussing new advances in respiratory virus challenge models improving their value for vaccine efficacy testing and host response disease monitoring. The World Vaccine Congress is an award-winning

hVIVO plc (formerly Open Orphan plc), led by Cathal Friel, is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and

Clinical trials are essential processes in the field of medicine, helping to determine the safety and effectiveness of new treatments, drugs, or medical procedures. These trials involve volunteers who agree to participate

Despite scientific progress made in the last decades, nearly 1 billion of individuals are affected by tropical diseases yearly, according to the World Health Organization. The development of new vaccines

Canary Wharf is set to receive a multi-million-pound cash injection to build more homes in the capital’s banking district. As part of the Spring Budget, Chancellor Jeremy Hunt announced he would pour

It’s no secret that women across a spectrum of industries often face challenges when trying to get ahead and make their mark in the business marketplace. The business development field

hVIVO plc (LON:HVO), a name not often headlined among the largest market cap companies, has recently led the AIM gainers, catching the eye of shareholders and investors alike. This surge